On November 6, HIPINE recorded an Intraday Rise of 9.19% in Regular Trading, with the stock trading at HK$53.7 and turnover of HK$59.2743 million.
The clearest recent catalyst is the company’s previously disclosed voluntary no-sale commitment from controlling shareholders and a major shareholder, which has continued to underpin sentiment around share-price stability and capital market confidence.
According to the company’s announcement, four controlling shareholders and major shareholder Jinyingu Investment committed not to directly or indirectly reduce any H shares for 12 months from October 30. The disclosed holdings covered about 66.72% of total shares. This followed an October 14 disclosure that one controlling shareholder had sold 100,000 shares, or about 0.17% of issued share capital, making the later lock-up style commitment more notable for investors assessing supply overhang risk.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)
Comments